The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis

Journal of Experimental Medicine

Volumn 189, Issue 6, 1999, Pages 957-967

  Hakem, Anne ^a   Sasaki, Takehiko ^a   Kozieradzki, Ivona ^a   Penninger, Josef M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b AMGEN INSTITUTE   (Canada)

Author keywords

Apoptosis; Cell cycle; Cyclin dependent kinase 2; Thymocyte

Indexed keywords

CYCLIN DEPENDENT KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME REGULATION; GENE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; THYMOCYTE; TRANSACTIVATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CDC2-CDC28 KINASES; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; FEMALE; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MITOCHONDRIA; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033559980     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.6.957     Document Type: Article

References (63)

1. White, E. 1993. Death-defying acts: a meeting review on apoptosis. Genes Dev. 7:2277-2284.
2. Russell, J.H., CL. White, D.Y. Loh, and R.-P. Meleedy. 1991. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad. Sci. USA. 88:2151-2155.
3. Green, D.R., and D.W. Scott. 1994. Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6:476-487.
4. King, L.B., and J.D. Ashwell. 1993. Signaling for death of lymphoid cells. Curr. Opin. Immunol. 5:368-373.
5. Martin, J.S., and R.D. Green. 1995. Protease activation during apoptosis: death by thousand cuts? Cell. 82:349-352.
6. Miller, D.K. 1997. The role of the Caspase family of cysteine proteases in apoptosis. Semin. Immunol. 9:35-49.
7. Cohen, G.M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326:1-16.
8. Salvesen, S.G., and M.V. Dixit. 1997. Caspases: intracellular signaling by proteolysis. Cell. 91:443-446.
9. Penninger, M.J., and G. Kroemer. 1998. Molecular and cellular mechanisms of T lymphocyte apoptosis. Adv. Immunol. 68:51-144.
10. Raff, M.C. 1992. Social controls on cell survival and cell death. Nature. 356:397-400.
11. Evan, G.I., L. Brown, M. Whyte, and E. Harrington. 1995. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 7:825-834.
12. Shi, L., W.K. Nishioka, J, Thang, E.M. Bradbury, D.W. Litchfield, and A.H. Greenberg. 1994. Premature p34cdc2 activation required for apoptosis. Science. 263:1143-1145.
13. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:119-128.
14. Mazel, S., D. Burtrum, and H.T. Petrie. 1996. Regulation of cell division cycle progression by Bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J. Exp. Med. 183:2219-2226.
15. Linette, G.P., Y. Li, K. Roth, and S.J. Korsmeyer. 1996. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. USA. 93:9545-9552.
16. Vairo, G., K.M. Innes, and J.M. Adams. 1996. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene. 13:1511-1519.
17. Bates, S., and K.H. Vousden. 1996. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6:12-18.
18. Brady, H.J., G. Gil-Gomez, J. Kirberg, and A.J. Berns. 1996. Bax alpha perturbs T cell development and affects cell cycle entry of T cells. EMBO (Eur. Mol. Biol. Organ.) J. 15:6991-7001.
19. Field, S.J., F.Y. Tsai, F. Kuo, A.M. Zubiaga, W.G. Kaelin, Jr., D.M. Livingston, S.H. Orkin, and M.E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 85:549-561.
20. Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and N.J. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell. 85:537-548.
21. Lotem, J., and L. Sachs. 1997. Cytokine suppression of protease activation in wild-type p53-dependent and p53-independent apoptosis. Proc. Natl. Acad. Sci. USA. 94:9349-9353.
22. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:849-852.
23. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:847-849.
24. Lee, E.Y., C.-Y. Chang, N. Hu, Y.-C. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defect in neurogenesis and haematopoiesis. Nature. 359:288-294.
25. Morgan, O.D. 1997. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13: 261-291.
26. Wang, J., and K. Walsh. 1996. Resistance to apoptosis conferred by Cdk inhibitors during myocyte apoptosis. Science. 273:359-361.
27. Park, D.S., B. Levine, G. Ferrari, and L.A. Greene. 1997. Cyclin dependent kinase and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J. Neurosci. 17:8975-8983.
28. Meikrantz, W., S. Gisselbrecht, S.W. Tam, and R. Schlegel. 1994. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. USA. 91:3754-3758.
29. Von Boehmer, H. 1996. CD4/CD8 lineage commitment: back to instruction? J. Exp. Med. 183:713-715.
30. lo thymocytes in vivo. Science. 250:1720-1723.
31. Strasser, A., A.W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889-899.
32. Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery, Jr., J.S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:215-221.
33. Pircher, H., T.W. Mak, R. Lang, W. Ballhausen, E. Rueedi, H. Hengartner, R.M. Zinkernagel, and K. Buerki. 1989. T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. EMBO (Eur. Mol. Biol. Organ.) J. 8:719-727.
34. Nishina, H., K.D. Fischer, L. Radvanyi, A. Shahinian, R. Hakem, E.A. Rubie, A. Bernstein, T.W. Mak, J.R. Woodgett, and J.M. Penninger. 1997. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature. 385:350-353.
35. Zamzami, N., P. Marchetti, M. Castedo, T. Hirsch, S.A. Susin, B. Masse, and G. Kroemer. 1996. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384:53-57.
36. Susin, S.A., N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1331-1341.
37. + thymocytes in vitro does not require dedicated antigen-presenting cells. Eur. J. Immunol. 23:669-674.
38. Sebzda, E., V.A. Wallace, J. Mayer, R.S. Yeung, T.W. Mak, and P.S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science. 263:1615-1618.
39. Meijer, L., and S.H. Kim. 1997. Chemical inhibitors of cyclin-dependent kinases. Methods Enzymol. 283:113-128.
40. Meikrantz, W., and R. Schlegel. 1996. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J. Biol. Chem. 271:10205-10209.
41. Rouquet, N., K. Carlier, P. Briand, J. Wiels, and V. Joulin. 1996. Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes. Biochem. Biophys. Res. Commun. 229: 27-35.
42. Smith, C.A., G.T. Williams, R. Kingston, E.J. Jenkinson, and J.J. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 337:181-184.
43. Kroemer, G., N. Zamzami, and S.A. Susin. 1997. Mitochondrial control of apoptosis. Immunol. Today. 18:44-51.
44. Vander Heiden, M.G., N.S. Chandel, E.K. Williamson, P.T. Schumacker, and C.B. Thompson. 1997. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:627-637.
45. Yang, J., X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.I. Peng, D.P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1129-1132.
46. Kluck, R.M., W.-E. Bossy, D.R. Green, and D.D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132-1136.
47. Liu, X., C.N. Kim, J. Pohl, and X. Wang. 1996. Purification and characterization of an interleukin-1beta-converting enzyme family protease that activates cysteine protease P32 (CPP32). J. Biol. Chem. 271:13371-13376.
48. Liu, X., C.N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:147-157.
49. Reed, J.C. 1997. Double identity for protein of the Bcl-2 family. Nature. 387:773-776.
50. Korsmeyer, S.J. 1995. Regulators of cell death. Trends Genet. 11:101-105.
51. Dou, Q.P., B. An, K. Antoku, and D.E. Johnson. 1997. Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family. J. Cell. Biochem. 64:586-594.
52. Tan, X., S.J. Martin, D.R. Green, and J.Y.J. Wang. 1997. Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J. Biol. Chem. 272:9613-9616.
53. Chen, W.D., G.A. Otterson, S. Lipkowitz, S.N. Khleif, A.B. Coxon, and F.J. Kaye. 1997. Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene. 14: 1243-1248.
54. Wang, Y., and C. Prives. 1995. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature. 376:88-91.
55. Marchetti, P., M. Castedo, S.A. Susin, N. Zamzami, T. Hirsch, A. Macho, A. Haeffner, F. Hirsch, M. Geuskens, and G. Kroemer. 1996. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184: 1155-1160.
56. Boehme, S.A., and M.J. Lenardo. 1996. TCR-mediated death of mature T lymphocytes occurs in the absence of p53. J. Immunol. 156:4075-4078.
57. McCurrach, M.E., T.M. Connor, C.M. Knudson, S.J. Korsmeyer, and S.W. Lowe. 1997. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA. 94:2345-2349.
58. Miyashita, T., S. Krajewski, M. Krajewska, H.G. Wang, H.K. Lin, D.A. Liebermann, B. Hoffman, and J.C. Reed. 1994. Tumor suppressor p53 is a regulator of Bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1799-1805.
59. Attardi, L.D., S.W. Lowe, J. Brugarolas, and T. Jacks. 1996. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO (Eur. Mol. Biol. Organ.) J. 15:3693-3701.
60. Krstic, D.M., I. Rogatsky, R.K. Yamamoto, and J.M. Garabedian. 1997. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17:3947-3954.
61. De Franco, D.B., M. Qi, K.C. Borror, M.J. Garabedian, and D.L. Brautigan. 1991. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol. Endocrinol. 5:1215-1228.
62. Hoecks, W., and B. Groner. 1990. Hormone-dependent phosphorylation of the glucocorticoid receptor occur mainly in the amino-terminal transactivation domain. J. Biol. Chem. 265:5403-5408.
63. Krucher, N.A., L. Meijer, and M.H. Roberts. 1997. The cyclin dependent kinase (cdk) inhibitors, olomoucine and roscovitine, alter the expression of a molluscan circadian pacemaker. Cell Mol. Neurobiol. 17:495-507.